PGY1 Pharmacy Roseville, California

The Kaiser Permanente Roseville PGY1 Residency is an ASHP accredited program. Our medical center is comprised of a 352 bed main hospital facility and a Women’s and Children’s hospital. It also includes four primary medical office complexes and is recognized as a Center of Excellence for Oncology. We proudly serve a diverse population of over 350,000 Kaiser Foundation Health Plan members in Sacramento and Placer counties. There are ambulatory care pharmacists in diverse practice areas and six Outpatient Pharmacies across four medical facilities that include locations in Roseville, Lincoln and Folsom.

---

Pharmacy Services

Our pharmacists and supportive personnel practice in inpatient, outpatient, ambulatory care and administration settings. Inpatient and outpatient pharmaceutical care services are provided 24 hours a day, seven days a week. Our medical center provides many outstanding opportunities for pharmacists to practice in collaboration with physicians, nurses, and other health professionals under an integrated healthcare model. The Inpatient Pharmacy includes clinical services in Acute Care/Critical Care Medicine, Antimicrobial Stewardship, Internal Medicine and Women’s and Children’s services, including Neonatal and Pediatric ICU. Our medical center takes advantage of technology in delivering care, including CPOE, EMAR, and bedside barcoding. The Ambulatory Care pharmacy services include Drug Use Management, Hepatology, Hospice, Medication Therapy Management, Osteoporosis, Oncology, Chronic Pain Management, Rheumatology and Preventing Heart Attacks and Strokes Everyday (PHASE). The Roseville Medical Center is also a teaching environment where students from UOP, CNUCOP, UCSF and Touro University rotate regularly.

Roseville At Glance

About Kaiser Permanente North Valley (Sacramento & Roseville)

 

 

---

Learning Experiences

Required Learning Experiences

• Acute Care :
  • Infectious Diseases
  • Intensive Care Unit
  • Women’s and Children’s (Neonatal & Pediatric Intensive Care Unit)
  • Hospital Floor Based (Internal Medicine)
• Ambulatory Care Services:
  • Medication Therapy Management
  • PHASE (Prevent Heart Attacks and Strokes Everyday)
  • Oncology
  • Drug Use Management
  • Outpatient

Required Longitudinal Learning Experiences

• Administration and Management (52 weeks)
• Residency Research Project (52 weeks)
• Precept Pharmacy Students (as available)
• Chief Resident (24 weeks)
• Optional Teaching Certificate Program (52 weeks)

Elective Learning Experiences

• Adult and Family Medicine
• Advanced Oncology
• Advanced PHASE
• Chronic Pain Management
• Hepatology
• Hospice
• Oncology and Specialty Drug Use Management
• Oral Chemotherapy
• Osteoporosis
• Rheumatology

---

Requirements for Acceptance

• Must be licensed as an Intern Pharmacist in the state of California by the first day of residency program.
• Resident must be a licensed California pharmacist within 120 days from the program start date. Residents who are not licensed as a pharmacist within 120 days from the program start date will have their term of appointment extended by the number of days the resident is without licensure past the 120-day deadline up to a maximum of 45 days. Failure to obtain a California state pharmacist license within 165 days from the program start date will result in the resident being dismissed from the program and employment will be terminated.
• To be eligible for pharmacist licensure, candidates must be graduates or candidates for graduation from an ACPE accredited degree program (or one in the process of pursuing accreditation) or have a Foreign Pharmacy Graduate Examination Committee (FPGEC) certificate from the NABP.
• For more information regarding licensing in California, please visit www.pharmacy.ca.gov
• Certifications (If applicable): BLS, ACLS
• Candidates must be registered in the National Matching Services, Inc. (NMS).
• Candidates must participate in the ASHP Matching Program.
• Program NMS Code: 205913 and ASHP Program Code: 92057

---

Application Requirements

• Statement of Interest/Letter of Intent
• Curriculum Vitae
• Official Pharmacy School transcripts, sent directly from the applicant’s college or school of pharmacy
• Three letters of reference/recommendation utilizing the form in PhORCAS is required for all reference writers.
• Completed PhORCAS Application
• Application Deadline: January 2, 2025

---

Interview Details

• On-Site or Virtual Interview Required
• Interview Dates: Approximately Beginning of February
• Click here to link to the Virtual Information Session:
  • November 7, 2024 – 1p.m. – 2p.m. PST
• Open House: Flyer: December 6, 2024 – 2:30p.m. – 5:00p.m. PST

**This residency agrees that no person at this residency will solicit, accept, or use any ranking-related information from any residency applicant**

Back to all programs